Vericel to Report Second Quarter 2026 Financial Results on July 30, 2026

Rhea-AI Summary

Vericel (NASDAQ:VCEL) announced it will release its second quarter 2026 financial results on Thursday, July 30, 2026. Management will host a conference call and live webcast at 8:30 a.m. ET to review financial results and business highlights, with access and replay available via the company’s Investor Relations website.

News Market Reaction – VCEL

+2.33%

1 alert

+2.33% Session close to close

$2.35B Market Cap

0.1x Rel. Volume

In the Jul 16 session, VCEL gained 2.33%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement of Vericel’s upcoming 2Q26 results comes against a backdrop of modest historical r...

Analysis

This announcement of Vericel’s upcoming 2Q26 results comes against a backdrop of modest historical reactions to earnings date notices, averaging -0.91%, and recent net insider selling totaling 65,607 shares over 90 days. With short interest flagged as low, investors may focus on how the forthcoming numbers compare with the previously raised 2026 guidance and whether insider net selling persists around the release.

Key Figures

Earnings release date: July 30, 2026 Conference call time: 8:30 a.m. ET Webcast replay end date: July 30, 2027 +1 more

4 metrics

Earnings release date July 30, 2026 Second quarter 2026 financial results report date

Conference call time 8:30 a.m. ET Start time for Q2 2026 results call

Webcast replay end date July 30, 2027 Expiration of replay availability for the webcast

Call passcode 567253 Passcode for telephone participation in earnings call

Previous Earnings date Reports

2 past events · Latest: Apr 23 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 23	Earnings date notice	Neutral	+0.1%	Scheduled reporting of first-quarter 2026 results and related conference call.
Feb 12	Earnings date notice	Neutral	-1.9%	Announcement of fourth-quarter and full-year 2025 results release date and call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Prior earnings date announcements for Vericel have led to modest, mixed share-price reactions, with an average move of -0.91% over the last two such events.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BURLINGTON, Mass., July 16, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will report its second quarter 2026 financial results on Thursday, July 30, 2026. Vericel’s management will host a conference call and webcast at 8:30 a.m. ET to discuss its financial results and business highlights.

The live webcast can be accessed on the Investor Relations section of the Vericel website at http://investors.vcel.com/events-presentations. Presentation slides for the conference call will be available on the webcast and on the website. A replay of the webcast will be available until July 30, 2027.

To participate by telephone, dial 800-330-6730 or +1-312-471-1351 if connecting from outside the U.S. When connected, please use passcode: 567253.

About Vericel Corporation
Vericel is a leading provider of advanced therapies for the sports medicine and severe burn care markets. The Company combines innovations in biology with medical technologies, resulting in a highly differentiated portfolio of innovative cell therapies and specialty biologics that repair injuries and restore lives. Vericel markets three products in the United States. MACI^® (autologous cultured chondrocytes on porcine collagen membrane) is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel^® (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. Vericel also holds an exclusive license for North American rights to NexoBrid^® (anacaulase-bcdb), a biological orphan product containing proteolytic enzymes, which is indicated for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness burns. For more information, please visit www.vcel.com. Epicel and MACI are registered trademarks of Vericel Corporation. NexoBrid is a registered trademark of MediWound Ltd. and is used under license to Vericel Corporation. © 2026 Vericel Corporation. All rights reserved.

Investor Contact: 
Eric Burns
ir@vcel.com
+1 (734) 418-4411

FAQ

When will Vericel (VCEL) report its Q2 2026 financial results?

Vericel will report its second quarter 2026 financial results on Thursday, July 30, 2026. According to Vericel, the release will be accompanied by a management conference call and webcast discussing financial results and key business highlights for the quarter.

What time is Vericel's Q2 2026 earnings conference call and webcast?

Vericel’s Q2 2026 conference call and webcast will begin at 8:30 a.m. Eastern Time on July 30, 2026. According to Vericel, management will discuss quarterly financial results and business highlights during this live event.

How can investors access the Vericel (VCEL) Q2 2026 earnings webcast?

Investors can access Vericel’s Q2 2026 webcast via the Investor Relations section of the company’s website at http://investors.vcel.com/events-presentations. According to Vericel, the webcast will include presentation slides and will be available live and as a replay.

What are the dial-in numbers for Vericel's Q2 2026 earnings call?

To join Vericel’s Q2 2026 call by phone, dial 800-330-6730 in the U.S. or +1-312-471-1351 internationally. According to Vericel, participants must use the passcode 567253 once connected to access the live conference.

How long will the replay of Vericel's Q2 2026 webcast be available?

The replay of Vericel’s Q2 2026 earnings webcast will be available until July 30, 2027. According to Vericel, investors can access the replay and presentation slides through the company’s Investor Relations website for a full year following the event.